Publications

Data were obtained from sample of 453 uveal melanoma survivors who completed observations 6?, 12?, 24?, 36?, 48? and 60?months postdiagnosis and missed no two consecutive observations.

Melanoma is the third most common cancer in the adolescent and young adult (AYA) population, however no studies have addressed the occurrence of adverse health conditions following melanoma treatment in these survivors.

Malignant melanomas in children and adolescents are thankfully rare, but they can be challenging to diagnose, and fatal disease can manifest itself in any of several different ways, results of a retrospective multicenter study showed.

Researchers focused on critically evaluating the available literature concerning survival of patients suffering from multiple primary melanomas (MPM) vs a single primary melanoma and describing statistical methods employed.